Stock Events

Stock Events

Viking Therapeutics (0VQA.LSE) Q3 2024 Earnings

24JulConfirmed

Q1 2024

Q3 2024

-0.28

-0.25

-0.23

-0.2

Details

Expected EPS

-0.262638

Actual EPS

-0.2

Surprise EPS

0.06

Surprise Percent

+23.85%

Description

Viking Therapeutics (0VQA.LSE) has reported earnings of -0.2 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.